九源基因股价大涨5.12% 骨优导®正式获印尼上市批准

港美通
Dec 02, 2025

12月2日10:33,九源基因(02566)股价大幅上涨5.12%。该股报8.210港元,最高报8.210港元,最低报7.970港元,成交量8.44万股,成交额68.05万港元。消息面上,近日,九源基因骨修复产品骨优导®(含BMP-2骨修复材料)获得印尼卫生部的正式上市批准。这是骨优导®首次进入东盟国家市场,标志着公司在全球化布局上迈出关键一步。杭州九源基因生物医药股份有限公司是一家中国生物制药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10